cluster	gene	p_val	avg_logFC	pct.1	pct.2	p_val_adj
2-1	CCL14	0.0E+00	2.17	83.2%	3.5%	0.0E+00
2-1	ACKR1	0.0E+00	2.15	66.8%	4.5%	0.0E+00
2-1	SELE	0.0E+00	2.12	56.3%	2.7%	0.0E+00
2-1	C2CD4B	0.0E+00	1.63	75.4%	8.4%	0.0E+00
2-1	CAVIN2	0.0E+00	1.43	84.0%	4.1%	0.0E+00
2-1	SOX18	0.0E+00	1.34	77.6%	2.5%	0.0E+00
2-1	EGFL7	0.0E+00	1.25	85.1%	2.1%	0.0E+00
2-1	VWF	0.0E+00	1.17	75.0%	1.3%	0.0E+00
2-1	A2M	0.0E+00	1.13	86.6%	7.2%	0.0E+00
2-1	CLDN5	0.0E+00	1.12	76.5%	0.9%	0.0E+00
2-1	AQP1	0.0E+00	1.08	68.7%	2.2%	0.0E+00
2-1	MMRN1	0.0E+00	1.03	35.8%	0.4%	0.0E+00
2-1	THBD	0.0E+00	0.96	81.0%	4.2%	0.0E+00
2-1	RAMP2	0.0E+00	0.94	82.5%	2.5%	0.0E+00
2-1	TFPI	0.0E+00	0.90	56.3%	3.0%	0.0E+00
2-1	ITM2A	0.0E+00	0.89	79.1%	7.8%	0.0E+00
2-1	GRASP	0.0E+00	0.88	79.5%	2.7%	0.0E+00
2-1	CD93	0.0E+00	0.83	69.8%	0.8%	0.0E+00
2-1	SLC2A3	0.0E+00	0.82	77.6%	5.3%	0.0E+00
2-1	PECAM1	0.0E+00	0.80	81.0%	0.8%	0.0E+00
2-1	EMCN	0.0E+00	0.74	79.5%	1.4%	0.0E+00
2-1	FAM110D	0.0E+00	0.74	60.1%	0.7%	0.0E+00
2-1	APOLD1	0.0E+00	0.73	73.1%	3.3%	0.0E+00
2-1	FLT1	0.0E+00	0.72	67.2%	0.4%	0.0E+00
2-1	ECSCR	0.0E+00	0.72	77.2%	0.4%	0.0E+00
2-1	ADGRL4	0.0E+00	0.71	75.0%	0.3%	0.0E+00
2-1	ENG	0.0E+00	0.71	73.5%	3.9%	0.0E+00
2-1	ENPP2	0.0E+00	0.65	51.9%	1.6%	0.0E+00
2-1	PIK3R3	0.0E+00	0.65	64.9%	4.1%	0.0E+00
2-1	CLEC14A	0.0E+00	0.63	66.4%	0.3%	0.0E+00
2-1	ADAMTS9	0.0E+00	0.63	65.3%	5.0%	0.0E+00
2-1	ESAM	0.0E+00	0.61	68.3%	1.6%	0.0E+00
2-1	ICAM2	0.0E+00	0.58	63.8%	1.3%	0.0E+00
2-1	LRRC32	0.0E+00	0.57	63.1%	4.2%	0.0E+00
2-1	DIPK2B	0.0E+00	0.54	63.4%	0.3%	0.0E+00
2-1	CD34	0.0E+00	0.54	60.4%	1.3%	0.0E+00
2-1	PLVAP	0.0E+00	0.51	53.7%	0.5%	0.0E+00
2-1	NES	0.0E+00	0.50	53.0%	3.1%	0.0E+00
2-1	RFLNB	0.0E+00	0.47	54.1%	1.8%	0.0E+00
2-1	TIMP3	1.8E-305	1.05	84.7%	11.3%	4.9E-301
2-1	TINAGL1	3.2E-296	0.51	68.3%	7.1%	8.8E-292
2-1	SPARC	7.8E-286	0.59	61.2%	5.8%	2.2E-281
2-1	RGS16	1.2E-258	0.88	59.7%	6.2%	3.4E-254
2-1	ADAMTS4	1.8E-237	0.82	59.0%	6.6%	5.1E-233
2-1	PMP22	4.1E-232	0.79	83.2%	14.9%	1.2E-227
2-1	STOM	4.5E-175	0.82	87.3%	25.1%	1.3E-170
2-1	EPAS1	2.7E-161	0.56	75.0%	15.6%	7.7E-157
2-1	GNG11	7.5E-157	1.20	99.3%	48.3%	2.1E-152
2-1	SRGN	1.6E-148	0.58	67.9%	13.0%	4.3E-144
2-1	PALM2-AKAP2	2.2E-148	0.61	68.7%	14.9%	6.0E-144
2-1	PNP	7.1E-147	0.92	81.7%	23.8%	2.0E-142
2-1	KLF2	7.5E-144	1.23	91.0%	31.5%	2.1E-139
2-1	TCF4	2.1E-135	0.68	88.1%	28.2%	5.9E-131
2-1	HLA-E	2.9E-133	0.99	100.0%	89.9%	8.2E-129
2-1	UPP1	1.0E-127	0.49	56.7%	10.7%	2.9E-123
2-1	PRSS23	1.9E-118	0.50	57.1%	11.7%	5.3E-114
2-1	TGFBR2	2.7E-118	0.53	75.7%	21.9%	7.5E-114
2-1	B2M	1.8E-104	0.82	100.0%	99.2%	5.0E-100
2-1	VIM	2.2E-104	1.14	100.0%	88.3%	6.1E-100
2-1	TMEM70	2.8E-104	0.62	75.7%	25.0%	8.0E-100
2-1	RCAN1	1.3E-103	0.57	60.1%	14.1%	3.7E-99
2-1	GJA1	3.4E-102	0.55	76.1%	23.6%	9.5E-98
2-1	HLA-B	5.6E-102	0.79	99.6%	96.8%	1.6E-97
2-1	MT1M	3.1E-101	0.63	39.2%	6.4%	8.7E-97
2-1	SPARCL1	5.4E-100	1.19	95.1%	54.8%	1.5E-95
2-1	CSRP2	1.4E-97	0.50	58.2%	13.8%	4.1E-93
2-1	HLA-A	6.4E-97	0.73	100.0%	95.0%	1.8E-92
2-1	PLPP3	1.3E-95	0.47	63.1%	16.6%	3.6E-91
2-1	VAMP5	1.5E-94	0.53	84.7%	32.1%	4.1E-90
2-1	DLC1	2.6E-94	0.58	82.1%	29.3%	7.4E-90
2-1	SOCS3	2.3E-92	1.01	97.8%	62.6%	6.5E-88
2-1	MT2A	2.6E-92	1.82	94.8%	56.2%	7.2E-88
2-1	EMP1	8.1E-92	1.03	98.5%	64.7%	2.3E-87
2-1	ID3	1.6E-91	1.28	88.4%	47.2%	4.5E-87
2-1	NDRG1	1.9E-90	0.55	79.9%	29.1%	5.4E-86
2-1	CD59	3.0E-84	0.67	98.9%	87.4%	8.4E-80
2-1	IFI27	6.1E-82	0.88	90.7%	44.5%	1.7E-77
2-1	IL6	1.1E-81	0.69	40.3%	8.1%	3.0E-77
2-1	SPTBN1	1.1E-80	0.63	87.3%	43.0%	3.1E-76
2-1	HLA-C	1.4E-79	0.62	100.0%	95.8%	3.9E-75
2-1	C11orf96	8.6E-78	1.16	86.2%	43.9%	2.4E-73
2-1	TMSB10	1.5E-77	0.62	100.0%	99.5%	4.3E-73
2-1	MT1X	1.2E-76	1.04	76.1%	32.8%	3.3E-72
2-1	GNAI2	9.1E-75	0.54	97.8%	77.9%	2.6E-70
2-1	IGFBP4	3.7E-71	0.71	95.9%	68.1%	1.0E-66
2-1	GADD45B	7.1E-71	0.86	98.5%	79.3%	2.0E-66
2-1	ARID5A	9.9E-71	0.50	70.5%	27.1%	2.8E-66
2-1	NNMT	2.9E-70	0.62	75.7%	29.1%	8.1E-66
2-1	SH3BGRL3	2.4E-69	0.59	97.4%	74.0%	6.7E-65
2-1	HYAL2	1.8E-68	0.63	88.1%	51.1%	5.2E-64
2-1	CAV1	3.4E-68	0.72	98.5%	77.8%	9.6E-64
2-1	CAVIN1	4.9E-64	0.47	91.0%	51.2%	1.4E-59
2-1	CSF3	2.3E-63	0.98	51.5%	15.5%	6.5E-59
2-1	LIFR	1.2E-62	0.47	72.8%	29.6%	3.2E-58
2-1	CCL21	7.1E-61	2.58	22.8%	3.6%	2.0E-56
2-1	ETS2	3.3E-60	0.66	96.6%	74.4%	9.3E-56
2-1	MGP	1.0E-59	0.96	77.6%	36.5%	2.9E-55
2-1	HSPA1A	9.7E-59	0.91	99.6%	87.2%	2.7E-54
2-1	TUBB6	4.5E-58	0.48	85.4%	45.6%	1.3E-53
2-1	CCDC85B	9.4E-57	0.61	94.0%	72.8%	2.6E-52
2-1	SELENOW	2.1E-56	0.51	98.5%	83.2%	5.8E-52
2-1	SPRY1	1.4E-55	0.59	81.3%	40.0%	3.8E-51
2-1	CDKN1A	6.9E-55	0.61	99.3%	75.5%	1.9E-50
2-1	ICAM1	3.3E-53	0.84	85.1%	48.4%	9.2E-49
2-1	IGFBP7	5.0E-52	0.55	100.0%	97.4%	1.4E-47
2-1	SOX17	3.6E-50	0.71	85.1%	51.0%	1.0E-45
2-1	ADAMTS1	1.1E-47	0.63	76.5%	37.3%	3.0E-43
2-1	TM4SF1	5.8E-45	0.63	100.0%	91.6%	1.6E-40
2-1	ID1	4.6E-43	0.70	88.8%	57.4%	1.3E-38
2-1	AKAP12	2.8E-42	0.73	86.6%	54.1%	7.8E-38
2-1	TFF3	3.1E-35	0.86	20.9%	4.8%	8.8E-31
2-1	KLF4	1.5E-34	0.51	83.6%	52.3%	4.3E-30
2-1	VCAM1	4.0E-31	0.51	44.0%	17.0%	1.1E-26
2-1	MT1E	1.4E-28	0.54	35.8%	13.0%	4.0E-24
2-1	PPFIBP1	4.8E-19	0.48	79.5%	54.7%	1.4E-14
2-2	C11orf96	0.0E+00	2.68	92.6%	41.6%	0.0E+00
2-2	IGFBP5	0.0E+00	2.26	88.5%	12.3%	0.0E+00
2-2	TPM2	0.0E+00	2.08	87.2%	34.4%	0.0E+00
2-2	DCN	0.0E+00	2.03	80.6%	13.8%	0.0E+00
2-2	MGP	0.0E+00	1.76	85.8%	34.0%	0.0E+00
2-2	PTGDS	0.0E+00	1.70	61.9%	13.3%	0.0E+00
2-2	LGALS1	0.0E+00	1.68	93.8%	43.0%	0.0E+00
2-2	SFRP4	0.0E+00	1.60	51.3%	3.3%	0.0E+00
2-2	MYH11	0.0E+00	1.28	53.7%	11.1%	0.0E+00
2-2	CNN1	0.0E+00	1.24	60.4%	12.1%	0.0E+00
2-2	RAMP1	0.0E+00	1.13	80.3%	10.1%	0.0E+00
2-2	CRISPLD2	0.0E+00	1.01	78.8%	7.4%	0.0E+00
2-2	COL1A1	0.0E+00	0.96	48.6%	4.3%	0.0E+00
2-2	COL3A1	0.0E+00	0.93	34.6%	1.2%	0.0E+00
2-2	TIMP3	0.0E+00	0.92	70.3%	8.9%	0.0E+00
2-2	ZNF331	0.0E+00	0.90	75.5%	23.6%	0.0E+00
2-2	COL6A2	0.0E+00	0.82	74.2%	12.0%	0.0E+00
2-2	SFRP1	0.0E+00	0.81	40.0%	1.8%	0.0E+00
2-2	SERPINF1	0.0E+00	0.79	60.0%	3.3%	0.0E+00
2-2	MEG3	0.0E+00	0.78	41.6%	1.2%	0.0E+00
2-2	SPARC	0.0E+00	0.76	53.1%	3.8%	0.0E+00
2-2	PPP1R14A	0.0E+00	0.74	45.5%	5.9%	0.0E+00
2-2	COL6A3	0.0E+00	0.71	43.8%	1.5%	0.0E+00
2-2	LUM	0.0E+00	0.70	30.4%	1.5%	0.0E+00
2-2	GEM	0.0E+00	0.63	52.3%	6.2%	0.0E+00
2-2	OGN	0.0E+00	0.63	32.4%	0.6%	0.0E+00
2-2	PLAC9	0.0E+00	0.62	38.6%	2.2%	0.0E+00
2-2	HSPB6	0.0E+00	0.60	63.7%	6.0%	0.0E+00
2-2	ADAMTS4	0.0E+00	0.60	49.2%	4.8%	0.0E+00
2-2	ACKR3	0.0E+00	0.56	39.3%	3.1%	0.0E+00
2-2	TIMP2	0.0E+00	0.51	63.6%	10.8%	0.0E+00
2-2	NEXN	0.0E+00	0.49	40.4%	2.8%	0.0E+00
2-2	MFAP4	0.0E+00	0.48	52.8%	3.7%	0.0E+00
2-2	SMTN	0.0E+00	0.47	47.6%	4.8%	0.0E+00
2-2	TGFB1I1	7.0E-294	0.52	56.1%	12.4%	2.0E-289
2-2	EMP3	5.7E-286	0.58	72.6%	22.0%	1.6E-281
2-2	FBLN1	4.5E-277	1.10	60.9%	16.9%	1.3E-272
2-2	SELENOM	1.5E-274	1.01	86.1%	40.4%	4.2E-270
2-2	IGFBP6	1.1E-271	1.41	72.4%	25.2%	3.0E-267
2-2	CALD1	2.0E-270	1.10	91.8%	63.7%	5.6E-266
2-2	SPARCL1	1.8E-267	1.18	94.8%	53.0%	5.1E-263
2-2	MCAM	7.5E-266	0.48	33.2%	4.4%	2.1E-261
2-2	FHL1	1.9E-256	0.58	66.4%	21.2%	5.4E-252
2-2	APOD	2.2E-249	0.49	25.5%	2.6%	6.1E-245
2-2	FILIP1L	9.9E-243	0.48	48.2%	10.3%	2.8E-238
2-2	ACTA2	3.6E-229	2.11	80.1%	46.2%	1.0E-224
2-2	MYLK	3.1E-218	1.27	67.7%	26.1%	8.8E-214
2-2	KLF2	3.0E-214	0.95	72.6%	30.0%	8.5E-210
2-2	KLF9	4.7E-213	0.54	69.1%	26.2%	1.3E-208
2-2	COL6A1	3.8E-190	0.63	66.6%	25.0%	1.1E-185
2-2	MUSTN1	6.4E-182	0.49	20.0%	2.2%	1.8E-177
2-2	TPM1	1.4E-180	0.91	95.3%	84.1%	3.8E-176
2-2	CREM	4.0E-165	0.59	77.0%	39.4%	1.1E-160
2-2	BST2	6.3E-163	0.52	84.6%	45.1%	1.8E-158
2-2	ADAMTS1	8.8E-163	0.73	77.6%	35.4%	2.5E-158
2-2	TAGLN	7.8E-161	1.84	89.4%	67.8%	2.2E-156
2-2	ID3	2.7E-151	0.73	81.6%	45.7%	7.5E-147
2-2	VIM	2.2E-150	0.75	98.3%	87.9%	6.0E-146
2-2	C7	8.2E-147	0.60	15.0%	1.5%	2.3E-142
2-2	S100A4	1.1E-144	0.74	64.1%	29.1%	3.1E-140
2-2	DES	2.6E-140	1.63	48.5%	17.9%	7.2E-136
2-2	ATP1B3	2.5E-138	0.79	77.5%	46.7%	6.9E-134
2-2	GADD45B	8.6E-135	0.81	94.8%	78.7%	2.4E-130
2-2	FLNA	9.5E-135	0.70	82.0%	56.6%	2.7E-130
2-2	MYC	9.9E-134	0.58	78.0%	44.3%	2.8E-129
2-2	IL6	1.1E-130	0.49	30.9%	7.3%	3.0E-126
2-2	MT1A	7.6E-128	0.69	23.0%	4.3%	2.1E-123
2-2	IGFBP4	7.1E-126	0.57	90.8%	67.1%	2.0E-121
2-2	UBB	4.1E-125	0.49	96.0%	88.0%	1.1E-120
2-2	ACTG2	2.5E-120	1.30	37.9%	12.3%	7.0E-116
2-2	JUNB	4.3E-118	0.53	98.5%	98.3%	1.2E-113
2-2	RARRES2	1.4E-116	0.50	92.6%	72.8%	3.8E-112
2-2	C1R	4.6E-116	0.49	73.4%	37.7%	1.3E-111
2-2	MYL9	9.0E-111	1.16	93.3%	86.0%	2.5E-106
2-2	SOCS3	2.3E-109	0.54	87.9%	61.7%	6.5E-105
2-2	ZCCHC12	9.1E-100	0.50	30.0%	8.5%	2.5E-95
2-2	COL1A2	1.2E-98	0.71	48.0%	17.8%	3.3E-94
2-2	UAP1	7.1E-96	0.48	62.1%	32.1%	2.0E-91
2-2	TUBA1A	3.3E-89	0.52	88.6%	75.3%	9.2E-85
2-2	DSTN	7.6E-89	0.54	97.4%	96.7%	2.1E-84
2-2	MT1M	2.2E-88	0.89	23.2%	6.0%	6.3E-84
2-2	MT2A	3.0E-88	1.56	77.8%	55.5%	8.4E-84
2-2	CSRP1	1.2E-86	0.64	92.6%	88.2%	3.3E-82
2-2	MT1E	1.5E-86	0.76	34.9%	12.0%	4.1E-82
2-2	HSPA1A	1.4E-80	0.73	93.7%	87.0%	3.9E-76
2-2	IGF1	1.4E-72	0.64	32.5%	12.1%	4.0E-68
2-2	HSPA6	3.5E-66	0.55	25.1%	8.3%	9.9E-62
2-2	CCDC80	2.0E-61	1.32	49.4%	25.9%	5.5E-57
2-2	MT1X	7.3E-48	0.76	53.2%	32.4%	2.0E-43
2-2	ADIRF	1.2E-28	0.52	92.7%	86.7%	3.4E-24
2-3	TXNIP	0.0E+00	0.84	80.4%	61.0%	0.0E+00
2-3	ATF3	0.0E+00	0.72	96.8%	93.0%	0.0E+00
2-3	ZFP36L1	0.0E+00	0.67	93.1%	80.8%	0.0E+00
2-3	BTG2	0.0E+00	0.54	94.4%	90.5%	0.0E+00
2-3	SNHG7	0.0E+00	0.53	91.3%	77.1%	0.0E+00
2-3	GAS5	0.0E+00	0.51	84.5%	82.9%	0.0E+00
2-3	JUNB	0.0E+00	0.49	98.6%	98.1%	0.0E+00
2-3	CIRBP	0.0E+00	0.48	98.6%	97.9%	0.0E+00
2-3	LYPD1	0.0E+00	0.47	88.3%	73.7%	0.0E+00
2-3	FOS	1.6E-269	0.63	97.2%	93.6%	4.6E-265
2-3	JUN	6.4E-169	0.53	97.8%	97.6%	1.8E-164
2-3	CRYAB	1.1E-68	0.69	81.5%	76.7%	3.2E-64
2-3	IGKC	8.7E-15	0.93	10.8%	15.4%	2.4E-10
2-4	CXCL1	0.0E+00	1.27	71.8%	43.5%	0.0E+00
2-4	CXCL8	0.0E+00	1.05	69.0%	37.4%	0.0E+00
2-4	LCN2	0.0E+00	1.00	97.4%	84.2%	0.0E+00
2-4	MMP7	0.0E+00	0.93	94.2%	76.5%	0.0E+00
2-4	SERPINB1	0.0E+00	0.89	97.0%	83.0%	0.0E+00
2-4	BIRC3	0.0E+00	0.81	96.2%	71.0%	0.0E+00
2-4	TFPI2	0.0E+00	0.77	85.0%	69.4%	0.0E+00
2-4	PTX3	0.0E+00	0.76	52.3%	16.8%	0.0E+00
2-4	PLAUR	0.0E+00	0.73	81.2%	44.7%	0.0E+00
2-4	SOD2	0.0E+00	0.63	99.6%	92.7%	0.0E+00
2-4	TNFAIP2	0.0E+00	0.60	90.7%	70.3%	0.0E+00
2-4	LAMB3	0.0E+00	0.58	76.3%	38.6%	0.0E+00
2-4	IL4I1	0.0E+00	0.57	71.2%	39.2%	0.0E+00
2-4	TNFRSF12A	0.0E+00	0.57	99.5%	91.8%	0.0E+00
2-4	S100A10	0.0E+00	0.51	100.0%	98.9%	0.0E+00
2-4	PRSS22	0.0E+00	0.51	68.4%	42.6%	0.0E+00
2-4	PHLDA2	0.0E+00	0.50	81.3%	56.1%	0.0E+00
2-4	TUBA1C	0.0E+00	0.50	97.2%	84.0%	0.0E+00
2-4	EZR	0.0E+00	0.48	97.5%	87.2%	0.0E+00
2-4	PDLIM1	0.0E+00	0.48	98.6%	91.0%	0.0E+00
2-4	KRT8	0.0E+00	0.48	99.9%	98.4%	0.0E+00
2-4	S100A6	0.0E+00	0.47	99.9%	98.0%	0.0E+00
2-4	CCL20	1.2E-235	0.91	37.9%	14.3%	3.2E-231
2-4	CXCL2	4.9E-209	0.59	93.9%	82.5%	1.4E-204
2-4	CCL2	2.1E-189	0.52	91.9%	79.6%	6.0E-185
2-4	KRT17	1.8E-181	0.55	84.8%	67.5%	5.0E-177
2-4	GJA4	2.4E-165	0.50	56.9%	38.0%	6.8E-161
2-5	OVGP1	0.0E+00	2.95	95.4%	19.6%	0.0E+00
2-5	CPM	0.0E+00	1.85	94.0%	26.7%	0.0E+00
2-5	PGR	0.0E+00	1.75	94.5%	30.0%	0.0E+00
2-5	PKHD1L1	0.0E+00	1.64	91.4%	15.0%	0.0E+00
2-5	COL1A2	0.0E+00	1.52	90.2%	16.8%	0.0E+00
2-5	CYP1B1	0.0E+00	1.52	90.9%	28.6%	0.0E+00
2-5	EPB41L2	0.0E+00	1.46	95.8%	41.8%	0.0E+00
2-5	MED24	0.0E+00	1.36	88.3%	24.9%	0.0E+00
2-5	SLC12A2	0.0E+00	1.33	93.1%	32.1%	0.0E+00
2-5	SLC26A2	0.0E+00	1.20	88.5%	20.3%	0.0E+00
2-5	GCLC	0.0E+00	1.18	90.3%	22.3%	0.0E+00
2-5	KIAA1324	0.0E+00	1.13	90.0%	14.4%	0.0E+00
2-5	TCN1	0.0E+00	1.05	50.1%	3.1%	0.0E+00
2-5	WDR77	0.0E+00	1.03	95.1%	34.1%	0.0E+00
2-5	PPM1L	0.0E+00	0.93	82.7%	11.1%	0.0E+00
2-5	SCUBE2	0.0E+00	0.93	82.7%	8.2%	0.0E+00
2-5	POSTN	0.0E+00	0.92	75.6%	7.2%	0.0E+00
2-5	SPATA13	0.0E+00	0.92	88.2%	21.5%	0.0E+00
2-5	LGR5	0.0E+00	0.89	82.7%	14.5%	0.0E+00
2-5	DAB2	0.0E+00	0.82	81.1%	18.7%	0.0E+00
2-5	HK2	0.0E+00	0.79	82.3%	14.4%	0.0E+00
2-5	HYOU1	0.0E+00	0.78	83.8%	21.1%	0.0E+00
2-5	SPDEF	0.0E+00	0.78	79.4%	11.1%	0.0E+00
2-5	TNFRSF19	0.0E+00	0.73	79.6%	19.1%	0.0E+00
2-5	INSIG1	0.0E+00	0.72	74.5%	14.7%	0.0E+00
2-5	MEGF9	0.0E+00	0.70	76.1%	17.3%	0.0E+00
2-5	MATN2	0.0E+00	0.67	74.7%	10.5%	0.0E+00
2-5	ACE	0.0E+00	0.66	74.1%	8.2%	0.0E+00
2-5	LINC01541	0.0E+00	0.66	63.2%	2.7%	0.0E+00
2-5	NPAS3	0.0E+00	0.66	78.9%	18.0%	0.0E+00
2-5	RIMS2	0.0E+00	0.64	71.2%	13.8%	0.0E+00
2-5	C1orf162	0.0E+00	0.62	72.9%	12.8%	0.0E+00
2-5	MMP26	0.0E+00	0.61	52.1%	3.5%	0.0E+00
2-5	CPNE5	0.0E+00	0.59	72.9%	9.7%	0.0E+00
2-5	SLC28A3	0.0E+00	0.59	71.0%	13.8%	0.0E+00
2-5	STARD4	0.0E+00	0.58	71.8%	10.4%	0.0E+00
2-5	PRSS12	0.0E+00	0.56	68.9%	10.9%	0.0E+00
2-5	COL12A1	0.0E+00	0.56	56.6%	6.3%	0.0E+00
2-5	PLCB4	0.0E+00	0.54	76.9%	14.3%	0.0E+00
2-5	AC078845.1	0.0E+00	0.51	63.9%	4.7%	0.0E+00
2-5	PGM2L1	2.8E-307	0.95	90.7%	30.6%	7.7E-303
2-5	ABCC4	2.0E-306	0.57	76.7%	17.2%	5.5E-302
2-5	ANO1	1.5E-301	0.59	76.0%	17.4%	4.3E-297
2-5	SEMA3C	5.0E-301	0.54	69.8%	13.7%	1.4E-296
2-5	GALNT4	8.9E-296	0.78	78.9%	20.0%	2.5E-291
2-5	ACSS2	1.1E-290	0.59	72.1%	16.0%	3.0E-286
2-5	SORL1	1.3E-289	1.36	98.4%	58.8%	3.7E-285
2-5	ITPRID2	1.9E-287	0.86	85.6%	26.9%	5.2E-283
2-5	ASRGL1	1.5E-284	1.37	99.1%	77.1%	4.1E-280
2-5	DNAJC10	2.7E-284	0.99	89.6%	32.7%	7.4E-280
2-5	ITGA6	6.2E-284	0.92	94.4%	36.6%	1.7E-279
2-5	ISG20	6.7E-283	0.90	86.2%	27.5%	1.9E-278
2-5	CPD	1.9E-281	0.82	91.8%	33.9%	5.4E-277
2-5	HMGCR	5.3E-281	0.76	79.1%	20.9%	1.5E-276
2-5	PDIA4	1.9E-277	1.37	94.4%	45.6%	5.4E-273
2-5	USP53	4.4E-277	1.58	98.4%	63.2%	1.2E-272
2-5	ARHGAP26	9.8E-274	1.00	94.9%	44.8%	2.7E-269
2-5	CRELD2	2.1E-270	0.97	86.5%	30.8%	5.8E-266
2-5	KCNK6	9.5E-270	0.91	82.0%	24.2%	2.7E-265
2-5	LBH	6.1E-267	1.16	90.5%	37.6%	1.7E-262
2-5	PDIA3	1.6E-266	1.28	99.5%	91.0%	4.4E-262
2-5	SLC7A2	7.6E-263	1.22	98.5%	60.2%	2.1E-258
2-5	AGR2	1.5E-262	1.49	96.2%	52.6%	4.2E-258
2-5	PLA2G4A	3.3E-261	0.64	84.7%	26.6%	9.1E-257
2-5	HSP90B1	1.1E-257	1.52	99.6%	96.6%	3.0E-253
2-5	C2orf88	1.8E-257	0.97	94.7%	40.8%	4.9E-253
2-5	HIF1A	8.8E-256	1.23	98.7%	73.0%	2.5E-251
2-5	HMGCS1	2.1E-255	0.96	84.5%	27.1%	5.8E-251
2-5	CALR	2.9E-255	1.20	99.5%	89.7%	8.2E-251
2-5	AP1S3	5.7E-253	0.53	67.4%	15.1%	1.6E-248
2-5	MARCKS	1.6E-251	1.36	99.6%	84.5%	4.4E-247
2-5	HSPA5	2.7E-250	1.47	99.5%	92.5%	7.5E-246
2-5	SPARCL1	9.7E-249	1.56	95.3%	54.0%	2.7E-244
2-5	EPS8	1.4E-248	0.66	84.5%	28.3%	3.9E-244
2-5	PDIA6	2.3E-246	1.03	98.7%	85.7%	6.6E-242
2-5	DLC1	3.0E-246	0.70	85.8%	28.0%	8.5E-242
2-5	MGST1	1.8E-245	1.13	98.2%	64.8%	5.2E-241
2-5	ELOVL5	4.3E-245	0.67	84.0%	28.0%	1.2E-240
2-5	LIPA	2.4E-244	0.60	77.6%	22.8%	6.7E-240
2-5	MTPN	3.3E-240	1.02	97.4%	73.1%	9.4E-236
2-5	RBBP7	5.5E-237	1.05	98.0%	71.3%	1.5E-232
2-5	SLC27A6	3.1E-236	0.48	76.7%	20.9%	8.7E-232
2-5	PTGS2	6.9E-235	1.16	80.7%	24.7%	1.9E-230
2-5	SPON1	6.2E-234	0.81	91.3%	36.4%	1.7E-229
2-5	SPTLC2	4.3E-232	0.67	86.3%	33.1%	1.2E-227
2-5	TSPAN13	4.7E-231	0.55	81.1%	26.5%	1.3E-226
2-5	CD55	1.7E-230	1.17	98.4%	69.6%	4.8E-226
2-5	XBP1	1.1E-227	0.99	99.1%	88.3%	3.1E-223
2-5	CBLB	1.2E-227	0.51	75.2%	21.1%	3.3E-223
2-5	ATP2A2	1.5E-227	0.73	92.3%	41.8%	4.3E-223
2-5	CD24	2.0E-227	1.03	99.1%	81.5%	5.5E-223
2-5	DNAJC3	2.9E-227	0.94	95.6%	57.0%	8.1E-223
2-5	LPAR3	1.1E-226	0.48	73.2%	19.5%	3.1E-222
2-5	SEC14L1	3.2E-225	0.70	87.6%	36.1%	9.0E-221
2-5	ITGA2	4.9E-225	0.51	69.9%	18.1%	1.4E-220
2-5	SLPI	4.2E-224	1.17	100.0%	99.5%	1.2E-219
2-5	NRIP1	1.0E-221	0.91	93.6%	46.5%	2.9E-217
2-5	ALCAM	1.5E-221	0.87	97.1%	63.4%	4.3E-217
2-5	IRS2	1.4E-219	0.70	86.3%	33.2%	3.9E-215
2-5	CANX	5.8E-219	0.85	99.1%	82.5%	1.6E-214
2-5	CRYBG1	3.3E-218	0.51	75.0%	21.5%	9.3E-214
2-5	SLC7A8	1.8E-217	0.64	85.6%	33.0%	4.9E-213
2-5	SERPINA3	2.4E-217	1.56	83.8%	32.6%	6.9E-213
2-5	PTPN4	1.4E-214	0.49	73.0%	20.8%	4.0E-210
2-5	GALNT7	2.7E-214	0.51	79.1%	25.4%	7.7E-210
2-5	SPCS3	7.6E-214	0.79	95.4%	57.7%	2.1E-209
2-5	DHCR24	1.1E-213	0.82	93.3%	47.0%	3.0E-209
2-5	MANF	1.3E-213	0.86	95.1%	56.8%	3.6E-209
2-5	WFDC2	5.7E-213	0.95	99.8%	99.8%	1.6E-208
2-5	GPD2	5.0E-212	0.50	80.9%	26.4%	1.4E-207
2-5	CD83	3.8E-208	1.04	87.2%	37.1%	1.1E-203
2-5	AIFM1	8.0E-208	0.68	91.4%	44.8%	2.2E-203
2-5	SERINC5	1.9E-207	0.68	89.3%	39.2%	5.2E-203
2-5	ABI3BP	5.0E-207	0.71	74.0%	22.6%	1.4E-202
2-5	SLC9A3R1	3.0E-205	0.81	92.3%	51.6%	8.3E-201
2-5	TMSB10	1.9E-204	0.74	99.8%	99.4%	5.2E-200
2-5	RNASE1	5.4E-204	1.22	95.4%	56.8%	1.5E-199
2-5	PLXDC2	1.5E-203	0.67	87.8%	36.4%	4.2E-199
2-5	MSMO1	1.2E-202	0.83	84.2%	34.5%	3.3E-198
2-5	ITGB8	1.6E-201	0.81	92.0%	46.0%	4.6E-197
2-5	CREB3L4	8.5E-198	0.52	73.6%	23.7%	2.4E-193
2-5	CYBA	1.0E-197	0.68	99.5%	96.4%	2.9E-193
2-5	GNB5	1.8E-196	0.62	85.4%	34.8%	5.1E-192
2-5	DLST	1.8E-194	0.51	75.6%	25.5%	5.0E-190
2-5	NOTCH2	2.4E-192	0.54	81.1%	29.6%	6.6E-188
2-5	ITGAV	6.2E-192	0.57	83.2%	31.8%	1.7E-187
2-5	MUC1	1.8E-191	0.75	100.0%	94.7%	4.9E-187
2-5	CST3	2.8E-191	0.92	100.0%	98.8%	8.0E-187
2-5	LYN	9.1E-191	0.63	81.8%	32.2%	2.5E-186
2-5	MT-ND5	1.6E-190	0.89	99.8%	98.1%	4.5E-186
2-5	GLIS3	2.0E-190	0.60	85.2%	35.3%	5.6E-186
2-5	FUT8	1.6E-189	0.48	77.2%	26.0%	4.5E-185
2-5	CMTM6	2.0E-189	0.80	99.3%	88.1%	5.5E-185
2-5	AHCYL1	5.5E-189	0.74	96.2%	64.2%	1.6E-184
2-5	TMED10	2.8E-188	0.66	98.7%	86.6%	7.7E-184
2-5	TMEM50B	2.2E-187	0.60	85.6%	37.7%	6.1E-183
2-5	SDF2L1	1.2E-186	0.79	94.2%	56.4%	3.4E-182
2-5	SQLE	8.8E-186	0.54	68.9%	20.6%	2.5E-181
2-5	NUCB2	1.4E-184	0.84	95.6%	63.4%	4.0E-180
2-5	MT-ND4L	1.6E-184	0.99	98.4%	82.5%	4.4E-180
2-5	CYP51A1	1.6E-184	0.91	88.7%	47.3%	4.4E-180
2-5	SLC38A2	1.1E-183	0.68	88.9%	38.2%	3.1E-179
2-5	SMIM14	2.6E-183	0.64	90.3%	44.4%	7.3E-179
2-5	SEL1L	3.0E-183	0.52	79.4%	29.5%	8.3E-179
2-5	COL18A1	3.6E-183	0.89	93.3%	62.7%	1.0E-178
2-5	ZBTB38	1.4E-182	0.83	93.6%	58.6%	4.0E-178
2-5	CERT1	7.9E-181	0.68	82.7%	35.4%	2.2E-176
2-5	IVNS1ABP	4.0E-179	0.55	80.9%	31.3%	1.1E-174
2-5	MYOF	1.1E-178	0.71	92.9%	50.9%	3.2E-174
2-5	VIM	9.2E-178	0.98	98.9%	88.1%	2.6E-173
2-5	PRKX	1.1E-177	0.66	91.6%	47.6%	2.9E-173
2-5	ESR1	2.4E-177	0.62	93.8%	51.7%	6.8E-173
2-5	PPM1K	4.6E-177	0.67	83.4%	35.2%	1.3E-172
2-5	SSR4	8.6E-177	0.72	99.5%	95.1%	2.4E-172
2-5	HIPK3	1.5E-176	0.66	91.1%	45.6%	4.3E-172
2-5	NET1	2.7E-176	0.70	92.2%	52.1%	7.4E-172
2-5	LDLR	7.2E-176	0.89	92.5%	51.1%	2.0E-171
2-5	MIA2	1.4E-175	0.53	80.5%	31.5%	3.8E-171
2-5	IFI16	2.7E-175	0.83	97.8%	74.6%	7.5E-171
2-5	HERPUD1	3.9E-175	0.94	95.8%	66.2%	1.1E-170
2-5	CLDN10	5.3E-175	0.81	98.0%	75.9%	1.5E-170
2-5	WNK1	8.6E-175	0.60	88.0%	43.3%	2.4E-170
2-5	GFPT1	1.0E-174	0.55	85.4%	35.8%	2.8E-170
2-5	MT-CO1	1.1E-174	0.53	99.8%	99.5%	3.0E-170
2-5	TLE1	5.3E-173	0.58	81.8%	33.8%	1.5E-168
2-5	HMGB3	7.5E-173	0.62	83.2%	38.3%	2.1E-168
2-5	ADAMTS1	1.3E-172	0.97	84.7%	36.1%	3.5E-168
2-5	SCARB2	1.5E-172	0.65	94.0%	55.6%	4.1E-168
2-5	SAT1	6.3E-172	0.92	100.0%	98.5%	1.8E-167
2-5	RBM47	6.9E-171	0.65	92.9%	52.1%	1.9E-166
2-5	MSI2	1.2E-170	0.54	89.3%	42.1%	3.3E-166
2-5	NFE2L1	1.4E-170	0.52	82.7%	34.4%	3.8E-166
2-5	PPP1CB	5.8E-170	0.67	99.3%	88.2%	1.6E-165
2-5	IDI1	6.7E-169	0.66	84.0%	37.6%	1.9E-164
2-5	FNDC3B	2.2E-168	0.51	85.2%	34.8%	6.1E-164
2-5	GOLGB1	1.7E-167	0.72	99.1%	72.9%	4.7E-163
2-5	AHR	2.9E-167	0.78	92.3%	57.9%	8.1E-163
2-5	CLTC	3.9E-166	0.58	90.7%	47.7%	1.1E-161
2-5	SLC1A5	5.4E-166	0.53	80.1%	33.5%	1.5E-161
2-5	MT-ATP8	8.3E-166	0.47	82.1%	31.0%	2.3E-161
2-5	TM9SF3	1.6E-165	0.60	96.4%	62.2%	4.6E-161
2-5	ATP1A1	7.7E-164	0.65	96.5%	72.0%	2.2E-159
2-5	RPN1	1.5E-163	0.60	91.6%	52.3%	4.2E-159
2-5	CD44	2.2E-163	0.76	93.3%	55.4%	6.0E-159
2-5	SLC34A2	2.4E-163	0.67	90.9%	50.0%	6.8E-159
2-5	PLCB1	2.8E-163	0.50	77.2%	28.8%	7.8E-159
2-5	KCNJ2	8.7E-162	0.47	51.9%	12.8%	2.4E-157
2-5	TC2N	9.0E-161	0.69	95.4%	61.9%	2.5E-156
2-5	MFHAS1	2.0E-160	0.58	82.5%	36.1%	5.5E-156
2-5	PNPLA8	5.5E-160	0.65	87.6%	43.9%	1.6E-155
2-5	EIF4G2	8.0E-160	0.61	98.9%	83.0%	2.3E-155
2-5	EFNB1	2.3E-159	0.54	80.1%	32.9%	6.4E-155
2-5	CNN3	1.4E-157	0.64	98.5%	87.2%	3.8E-153
2-5	SLC40A1	1.7E-157	0.78	99.3%	87.3%	4.7E-153
2-5	SEC61A1	3.0E-157	0.48	82.5%	35.6%	8.3E-153
2-5	BCAP29	1.5E-156	0.54	81.6%	35.4%	4.3E-152
2-5	RRBP1	2.8E-156	0.65	96.4%	73.5%	7.8E-152
2-5	STX18	5.5E-156	0.55	88.3%	44.7%	1.5E-151
2-5	MAGT1	3.0E-155	0.55	88.2%	45.9%	8.4E-151
2-5	MRPL33	5.8E-155	0.59	98.5%	86.9%	1.6E-150
2-5	DSP	7.9E-155	0.77	96.5%	70.7%	2.2E-150
2-5	ATP5ME	2.2E-154	0.56	99.6%	95.2%	6.2E-150
2-5	AZIN1	5.5E-154	0.53	88.2%	43.8%	1.5E-149
2-5	NORAD	5.5E-154	0.61	96.2%	69.7%	1.6E-149
2-5	IQGAP1	8.1E-153	0.63	96.9%	72.5%	2.3E-148
2-5	QSOX1	4.6E-152	0.54	84.9%	41.6%	1.3E-147
2-5	HIVEP2	5.9E-151	0.53	80.7%	34.0%	1.6E-146
2-5	CNDP2	2.4E-150	0.57	95.4%	62.5%	6.7E-146
2-5	DDR1	4.3E-150	0.55	91.3%	53.5%	1.2E-145
2-5	INSR	5.8E-150	0.69	96.5%	68.4%	1.6E-145
2-5	CD46	7.7E-150	0.66	96.9%	77.8%	2.2E-145
2-5	STT3B	1.4E-149	0.49	83.4%	39.0%	3.9E-145
2-5	ADD3	1.6E-149	0.60	89.6%	48.8%	4.4E-145
2-5	PREX2	7.9E-149	0.47	75.2%	28.9%	2.2E-144
2-5	PPIB	1.0E-148	0.55	99.3%	97.7%	2.8E-144
2-5	LONRF2	2.5E-148	0.57	86.3%	38.7%	7.1E-144
2-5	HNRNPA2B1	4.7E-148	0.51	100.0%	97.3%	1.3E-143
2-5	TBC1D1	3.4E-147	0.53	85.6%	41.8%	9.4E-143
2-5	TSPAN3	1.6E-145	0.53	98.2%	82.8%	4.4E-141
2-5	CRISP3	8.4E-145	1.15	95.8%	92.5%	2.3E-140
2-5	ANXA5	2.1E-144	0.55	99.1%	91.8%	5.9E-140
2-5	ITPR2	7.7E-144	0.57	84.9%	42.0%	2.1E-139
2-5	ATP8B1	2.3E-143	0.49	79.6%	34.1%	6.5E-139
2-5	SPRY1	1.4E-142	0.74	82.3%	39.1%	4.0E-138
2-5	SSR3	3.1E-141	0.55	98.4%	84.7%	8.6E-137
2-5	ACSL4	1.0E-139	0.49	78.9%	34.5%	2.8E-135
2-5	MAP4	4.5E-139	0.55	92.5%	56.7%	1.3E-134
2-5	LAMP2	5.9E-139	0.51	92.0%	52.5%	1.6E-134
2-5	SMIM22	3.1E-138	0.57	95.1%	66.2%	8.7E-134
2-5	TMED7	7.6E-137	0.52	88.3%	48.9%	2.1E-132
2-5	BAG5	1.7E-135	0.56	87.6%	50.9%	4.7E-131
2-5	EIF4G1	6.3E-135	0.50	90.5%	50.4%	1.8E-130
2-5	CEP70	7.6E-135	0.47	80.1%	36.6%	2.1E-130
2-5	AR	9.2E-135	0.60	95.8%	71.7%	2.6E-130
2-5	TACC1	1.3E-134	0.64	95.8%	70.9%	3.6E-130
2-5	TFRC	2.0E-134	0.50	84.9%	41.1%	5.5E-130
2-5	FBXO21	2.3E-134	0.57	99.6%	90.2%	6.4E-130
2-5	FNDC3A	2.6E-133	0.54	90.0%	53.3%	7.4E-129
2-5	MECOM	2.0E-132	0.50	78.0%	35.5%	5.7E-128
2-5	FRMD4B	2.3E-131	0.66	90.3%	54.7%	6.5E-127
2-5	TM9SF2	2.1E-130	0.47	85.8%	45.7%	5.8E-126
2-5	CLIP1	8.3E-130	0.51	82.9%	39.3%	2.3E-125
2-5	PJA2	4.2E-128	0.50	90.3%	53.7%	1.2E-123
2-5	C1orf122	4.2E-128	0.51	90.7%	51.7%	1.2E-123
2-5	CKB	7.1E-128	0.74	98.4%	88.5%	2.0E-123
2-5	PODXL	1.1E-127	0.75	82.0%	43.5%	3.2E-123
2-5	TPM3	4.6E-127	0.61	97.6%	88.2%	1.3E-122
2-5	CCNA1	2.3E-126	0.47	67.8%	24.5%	6.3E-122
2-5	SGK1	2.4E-126	0.49	74.7%	30.8%	6.6E-122
2-5	KMT2C	7.8E-126	0.50	83.8%	42.7%	2.2E-121
2-5	ACTN1	8.4E-126	0.50	93.1%	59.3%	2.3E-121
2-5	XIST	1.3E-124	0.67	96.5%	71.8%	3.6E-120
2-5	MACF1	3.5E-124	0.50	90.7%	51.7%	9.9E-120
2-5	USP9X	4.9E-124	0.50	88.0%	50.3%	1.4E-119
2-5	BBX	7.6E-124	0.57	92.0%	61.7%	2.1E-119
2-5	DNAJB11	1.0E-123	0.51	86.9%	50.7%	2.9E-119
2-5	RPN2	2.0E-123	0.50	95.6%	72.1%	5.5E-119
2-5	TTC3	1.2E-122	0.55	95.4%	71.6%	3.2E-118
2-5	TXNRD1	4.6E-121	0.59	90.5%	55.1%	1.3E-116
2-5	RHOU	3.2E-117	0.48	77.2%	36.2%	8.9E-113
2-5	KTN1	3.6E-116	0.49	98.5%	84.0%	1.0E-111
2-5	CYB5A	5.0E-116	0.48	97.4%	84.6%	1.4E-111
2-5	ITGB1	1.2E-114	0.47	96.9%	75.0%	3.4E-110
2-5	HDLBP	2.0E-114	0.48	94.5%	70.6%	5.5E-110
2-5	CTNNA1	6.7E-114	0.47	93.1%	65.2%	1.9E-109
2-5	F11R	6.8E-114	0.49	88.0%	51.9%	1.9E-109
2-5	P4HB	8.4E-113	0.48	95.1%	71.2%	2.4E-108
2-5	PBX1	1.3E-111	0.50	93.3%	63.1%	3.6E-107
2-5	FOSL2	3.0E-110	0.52	86.5%	50.6%	8.5E-106
2-5	SLFN5	5.8E-110	0.55	89.4%	56.4%	1.6E-105
2-5	AGR3	2.5E-108	0.69	88.0%	55.2%	7.1E-104
2-5	CLU	3.7E-106	0.60	100.0%	99.9%	1.0E-101
2-5	NEAT1	1.8E-105	0.80	98.2%	87.9%	5.1E-101
2-5	GSN	2.0E-105	0.52	99.6%	96.0%	5.6E-101
2-5	NEDD9	3.3E-104	0.54	83.4%	47.5%	9.1E-100
2-5	PRRC2C	1.3E-100	0.48	98.7%	85.7%	3.6E-96
2-5	WSB1	3.3E-100	0.53	93.3%	71.2%	9.2E-96
2-5	TMOD3	6.5E-99	0.49	97.4%	78.8%	1.8E-94
2-5	KLF5	9.7E-98	0.65	97.1%	83.2%	2.7E-93
2-5	AMD1	5.4E-97	0.50	94.9%	73.8%	1.5E-92
2-5	GOLGA4	8.0E-96	0.47	94.2%	68.8%	2.2E-91
2-5	WEE1	1.6E-91	0.59	87.1%	55.0%	4.5E-87
2-5	EHF	4.5E-89	0.51	94.9%	74.0%	1.3E-84
2-5	SCGB1D2	3.5E-87	1.24	87.2%	57.4%	9.9E-83
2-5	TGM2	1.8E-86	0.64	75.6%	42.5%	5.1E-82
2-5	SCGB3A1	4.2E-70	0.68	93.3%	68.1%	1.2E-65
2-5	IFI27	4.2E-46	0.59	68.9%	44.4%	1.2E-41
2-6	SRGN	0.0E+00	1.91	95.6%	12.2%	0.0E+00
2-6	IL7R	0.0E+00	1.40	50.3%	1.1%	0.0E+00
2-6	CCL5	0.0E+00	1.13	43.0%	0.8%	0.0E+00
2-6	PTPRC	0.0E+00	1.08	73.4%	1.2%	0.0E+00
2-6	CD69	0.0E+00	1.08	64.9%	3.1%	0.0E+00
2-6	SAMSN1	0.0E+00	0.75	65.8%	1.2%	0.0E+00
2-6	CPA3	0.0E+00	0.67	20.3%	0.4%	0.0E+00
2-6	LCP1	0.0E+00	0.66	57.9%	2.6%	0.0E+00
2-6	TRBC2	0.0E+00	0.60	44.3%	0.4%	0.0E+00
2-6	CD7	0.0E+00	0.60	42.4%	0.7%	0.0E+00
2-6	CD52	0.0E+00	0.59	54.7%	0.5%	0.0E+00
2-6	ALOX5AP	0.0E+00	0.58	52.5%	1.7%	0.0E+00
2-6	CD2	0.0E+00	0.56	48.7%	0.3%	0.0E+00
2-6	RGS1	0.0E+00	0.56	45.9%	0.9%	0.0E+00
2-6	KLRB1	0.0E+00	0.55	35.4%	0.5%	0.0E+00
2-6	BATF	0.0E+00	0.54	35.8%	1.5%	0.0E+00
2-6	CD3E	0.0E+00	0.54	50.6%	0.3%	0.0E+00
2-6	CST7	0.0E+00	0.53	45.6%	0.5%	0.0E+00
2-6	CD37	0.0E+00	0.49	52.5%	0.7%	0.0E+00
2-6	CYTIP	0.0E+00	0.47	47.2%	0.7%	0.0E+00
2-6	TPSAB1	1.9E-201	1.59	21.8%	1.0%	5.4E-197
2-6	STK17B	1.2E-154	0.57	64.9%	14.4%	3.4E-150
2-6	S100A4	2.4E-151	0.94	86.1%	30.0%	6.7E-147
2-6	SMAP2	7.6E-143	0.48	56.3%	11.5%	2.1E-138
2-6	CXCR4	5.4E-130	1.17	67.7%	20.5%	1.5E-125
2-6	ARHGDIB	6.7E-119	0.79	84.5%	37.9%	1.9E-114
2-6	RGS2	5.8E-102	0.54	49.7%	11.5%	1.6E-97
2-6	TPSB2	1.8E-101	2.14	22.5%	2.5%	4.9E-97
2-6	B2M	9.0E-86	0.65	100.0%	99.2%	2.5E-81
2-6	BTG1	3.2E-85	1.00	94.6%	78.6%	9.0E-81
2-6	CCL4	2.3E-84	1.08	37.3%	7.9%	6.5E-80
2-6	LEPROTL1	1.9E-75	0.57	70.9%	31.9%	5.4E-71
2-6	ETS1	3.8E-73	0.58	64.2%	24.6%	1.1E-68
2-6	CREM	3.7E-71	0.80	76.6%	40.9%	1.0E-66
2-6	TSC22D3	9.6E-62	0.83	80.4%	47.6%	2.7E-57
2-6	SH3BGRL3	1.1E-55	0.53	92.4%	74.1%	3.2E-51
2-6	IL32	9.3E-52	0.59	78.5%	44.3%	2.6E-47
2-6	AREG	6.7E-49	0.67	71.2%	33.9%	1.9E-44
2-6	DDIT4	6.0E-42	0.53	75.6%	44.2%	1.7E-37
2-6	VIM	4.9E-35	0.64	94.0%	88.4%	1.4E-30
2-6	FAM107B	1.2E-30	0.50	59.2%	33.9%	3.3E-26
2-6	TNFAIP3	1.9E-30	0.55	86.7%	63.6%	5.2E-26